Delorbis Pharmaceuticals Ltd., Lek Pharmaceuticals d.d., Salutas Pharma
PolandAll drugs from this manufacturer
-
This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01